Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Cost-effectiveness of diagnostic interventions: Non-small cell lung cancer.
Onkologe 16, 992-1002 (2010)
DOI Verlagsversion bestellen
The present article is intended as an introduction to health economic evaluation as well as a review of economic evaluations of positron emission tomography (PET and PET/CT) in the diagnosis and management of non-small cell lung cancer. Furthermore, the transferability of the results of economic evaluations in other countries to the German health care context is assessed. With the help of a literature search 13 full health economic evaluations of staging (12 studies) and follow-up (1 study) of non-small cell lung cancer were identified. The primary health benefit measure was life years gained or quality-adjusted life years gained. All of these evaluations were based on modeling studies. Due to differences in assumptions and methodological heterogeneity, the incremental cost-effectiveness ratios varied widely. Because of the complexity of the diagnostic and therapeutic process, the transferability of international study results to the German situation is limited. The cost-effectiveness of PET for other management decisions in non-small cell lung cancer (e.g. radiotherapy planning) is still to be assessed.
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter 18F-Fluorodeoxyglucose; Positron-emission tomography; Computed tomography; Non-small cell lung cancer; Cost effectiveness; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; TECHNOLOGY-ASSESSMENT; PATIENT-MANAGEMENT; IMPACT; CARCINOMA; ONCOLOGY; RECOMMENDATIONS; ACCURACY; STRATEGY
ISSN (print) / ISBN 0947-8965
Zeitschrift Onkologe, Der
Quellenangaben Band: 16, Heft: 10, Seiten: 992-1002
Verlagsort New York